WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

CLINICAL PHARMACOLOGY OF CEPHALOSPORINS IN INFANTS AND CHILDREN

Prof. Gian Maria Pacifici

ABSTRACT

The cephalosporins used to treat paediatric infections are: cefalexin, cefradine, and cefaclor (first-generation cephalosporins) cefuroxime, and ceflacor (second-generation cephalosporins), cefixime, cefotaxime, and ceftriaxone (third-generation cephalosporins), and ceftazidime (antipseudomonal cephalosporin). Cefalexin, cefuroxime, cefotaxime, ceftriazone, and cefotaxime are used to treat newborns and children, whereas cefradine, cefadroxil, ceflacor and cefixime are used to treat children. The pharmacokinetics of these cephalosporins have been studied and the elimination half-life of cefalexin, cefradine, cefadroxil, cefuroxime, ceflacor, cefixime, cefotaxime, ceftriaxone, cefotaxime, and ceftazidime ranges from 0.8 to 2.1 hours, whereas that of ceftriaxone is about 5.5 hours. The treatment of infections caused by different bacteria has been described for cefalexin, cefradine, cefadroxil, cefuroxime, cefaclor, cefixime, cefotaxime, ceftriaxone, and ceftazidime. Cefalexin, cefuroxime, cefotaxime, desacetylcefotaxime, ceftriaxone, and ceftazidime penetrate into the cerebrospinal fluid of infants and children in significant amounts. Cefalexin, cefuroxime, cefaclor, cefotaxime, desacetylcefotaxime, ceftriaxone, and ceftazidime successfully treated the meningitis caused by different bacteria in infants and children. The transfer of cefradine, cefuroxime, ceftriazone, and ceftazidime across the human placenta has been reported and these cephalosporins are promptly transferred from the maternal serum to the umbilical cord serum. Cefazolin, cefradine, cefadroxil, cefuroxime, cefaclor, cefotaxime, ceftriaxone and ceftazidime poorly migrate into the breast-milk. The aim of this study is to review administration, pharmacokinetics, treatment of bacterial infections, penetration into the cerebrospinal fluid, treatment of bacterial meningitis, transfer across the human placenta, and migration into the breast-milk for cefalexin cefradine, cefadroxil, cefuroxime, cefaclor, cefixime, cefotaxime, ceftriaxone, and ceftazidime.

Keywords: Breast-milk, cephalosporins, cerebrospinal fluid, dosing, meningitis, pharmacokinetics, placental-transfer, and treatment.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More